aPROMISE 自动化解剖定位、检测与定量 [18F]DCFPyL(PSMA)成像的分析性能:面向标准化报告
本研究对软件即医疗器械 aPROMISE 进行解析验证,该软件用深度学习在低剂量 CT 上分割器官,并检测和定量 PSMA PET/CT 潜在病灶。20 例患者的分割 Dice 评分与手动分割比较,339 例前列腺癌患者(OSPREY 研究)评估定量一致性和病灶检测灵敏度。结果显示分割准确、定量一致性优于手动读者间一致性,区域淋巴结检测灵敏度 91.5%。
要点
- aPROMISE 在低剂量 CT 上的器官分割 Dice 评分均较高,肝脏达 0.97。
- aPROMISE 定量一致性优于手动读者间一致性,参考器官摄取值标准差更低。
- 转移患者中病灶检测与预分割灵敏度:区域淋巴结 91.5%、骨 86.7%。
核心结论
- aPROMISE 的深度学习分割准确,多读者间定量评估一致,检测潜在病灶灵敏度高,为 PSMA PET/CT 标准化报告提供框架。
研究设计与样本
- 用 20 例患者 PSMA PET/CT 的低剂量 CT 比较自动与手动分割,以 Dice 评分量化相似性。
- 在 339 例前列腺癌患者(均入组 II/III 期 OSPREY 研究)中评估参考器官摄取的自动定量及潜在病灶的检测与预分割。
- 由三名核医学医师使用 aPROMISE 对 OSPREY 图像进行回顾性独立阅片。
主要发现
- 骨分割 Dice 评分范围为 0.88 至 0.95。
- PSMA PET/CT 参考器官胸主动脉和肝脏的 Dice 评分分别为 0.89 和 0.97。
- 包括前列腺在内的其他内脏器官 Dice 评分均高于 0.79。
- 血池参考的 Pearson 相关性在任何手动读者与 aPROMISE 之间均高于任何两名手动读者之间。
- aPROMISE 测得的参考器官摄取值标准差(血池 SD=0.21,肝脏 SD=1.16)低于手动读者。
关键数值与推荐
- 分割准确性以 Dice 评分评估,骨 0.88–0.95,胸主动脉 0.89,肝脏 0.97,其他内脏器官>0.79。
- 定量一致性以 Pearson 相关性和标准差评估,aPROMISE 血池 SD=0.21、肝脏 SD=1.16,低于手动读者。
- 病灶检测灵敏度:区域淋巴结 91.5%,所有淋巴结 90.6%,骨 86.7%。
临床怎么用
- aPROMISE 可用于 PSMA PET/CT 的器官自动分割和参考器官摄取值定量,辅助标准化报告。
- 其病灶检测与预分割高灵敏度可帮助识别区域淋巴结和骨病灶,但需临床验证后用于常规报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The application of automated image analyses could improve and facilitate standardization and consistency of quantification in [18F]DCFPyL (PSMA) PET/CT scans. In the current study, we analytically validated aPROMISE, a software as a medical device that segments organs in low-dose CT images with deep learning, and subsequently detects and quantifies potential pathological lesions in PSMA PET/CT. METHODS: To evaluate the deep learning algorithm, the automated segmentations of the low-dose CT component of PSMA PET/CT scans from 20 patients were compared to manual segmentations. Dice scores were used to quantify the similarities between the automated and manual segmentations. Next, the automated quantification of tracer uptake in the reference organs and detection and pre-segmentation of potential lesions were evaluated in 339 patients with prostate cancer, who were all enrolled in the phase II/III OSPREY study. Three nuclear medicine physicians performed the retrospective independent reads of OSPREY images with aPROMISE. Quantitative consistency was assessed by the pairwise Pearson correlations and standard deviation between the readers and aPROMISE. The sensitivity of detection and pre-segmentation of potential lesions was evaluated by determining the percent of manually selected abnormal lesions that were automatically detected by aPROMISE. RESULTS: The Dice scores for bone segmentations ranged from 0.88 to 0.95. The Dice scores of the PSMA PET/CT reference organs, thoracic aorta and liver, were 0.89 and 0.97, respectively. Dice scores of other visceral organs, including prostate, were observed to be above 0.79. The Pearson correlation for blood pool reference was higher between any manual reader and aPROMISE, than between any pair of manual readers. The standard deviations of reference organ uptake across all patients as determined by aPROMISE (SD = 0.21 blood pool and SD = 1.16 liver) were lower compared to those of the manual readers. Finally, the sensitivity of aPROMISE detection and pre-segmentation was 91.5% for regional lymph nodes, 90.6% for all lymph nodes, and 86.7% for bone in metastatic patients. CONCLUSION: In this analytical study, we demonstrated the segmentation accuracy of the deep learning algorithm, the consistency in quantitative assessment across multiple readers, and the high sensitivity in detecting potential lesions. The study provides a foundational framework for clinical evaluation of aPROMISE in standardized reporting of PSMA PET/CT.
引用
- Johnsson K, Brynolfsson J, Sahlstedt H, et al. Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting. Eur J Nucl Med Mol Imaging. 2021. PMID: 34463809. doi:10.1007/s00259-021-05497-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。